Skip to main content
Erschienen in: Clinical Rheumatology 11/2014

01.11.2014 | Brief Report

Efficacy of an out-patient pain management programme for people with joint hypermobility syndrome

verfasst von: Anisur Rahman, Clare Daniel, Rodney Grahame

Erschienen in: Clinical Rheumatology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Joint hypermobility syndrome (JHS) is common in patients presenting to rheumatologists and can cause a range of symptoms leading to physical and psychological distress. Chronic musculoskeletal pain in patients with JHS often responds poorly to analgesics, and a pain management approach may be helpful. Since patients with JHS often have beliefs and experiences different to those of other chronic pain patients, they could fare better in JHS-specific programmes. Here, we report on the outcomes of patients in a JHS cognitive behavioural pain management programme. Patients fulfilling the Brighton criteria for JHS, who had suffered pain for at least 3 months, were assessed by a psychologist and physiotherapist for suitability for this programme. Those accepted took part in a programme of 8 days spread over 6 weeks, delivered by a multidisciplinary team and incorporating a cognitive behavioural approach. Outcomes were assessed at baseline, 1- and 5-month post-programme using validated outcome measures. Outcome measures at baseline and 1-month were available for 87 patients (96 % female, mean age 35 years). There were significant improvements in self-efficacy, pain catastrophising, depression, anxiety, frustration, impact of pain and average pain intensity (all P < 0.001). Although by 5 months all these outcomes had regressed towards pre-programme levels there remained significant improvements compared to baseline in all except average pain intensity. This open study shows that patients with JHS experienced significant benefits after attending a JHS-specific pain management programme, which were still evident 5 months later. Longer-term controlled studies are required.
Literatur
1.
Zurück zum Zitat Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27(7):1777–1779PubMed Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27(7):1777–1779PubMed
2.
Zurück zum Zitat Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Gene 149A(11):2368–2370CrossRef Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Gene 149A(11):2368–2370CrossRef
3.
Zurück zum Zitat Grahame R, Hakim AJ (2006) Joint hypermobiilty syndrome is highly prevalent in general rheumatology clinics, its occurrence and clinical presentation being gender, age and race-related. Ann Rheum Dis 65(Suppl ii):263 Grahame R, Hakim AJ (2006) Joint hypermobiilty syndrome is highly prevalent in general rheumatology clinics, its occurrence and clinical presentation being gender, age and race-related. Ann Rheum Dis 65(Suppl ii):263
4.
Zurück zum Zitat Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Practice 4(10):522–524 Grahame R (2008) Hypermobility: an important but often neglected area within rheumatology. Nat Clin Practice 4(10):522–524
5.
Zurück zum Zitat Voermans NC, Knoop H, Bleijenberg G, Van Engelen BG (2010) Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage 40(3):370–378PubMedCrossRef Voermans NC, Knoop H, Bleijenberg G, Van Engelen BG (2010) Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage 40(3):370–378PubMedCrossRef
6.
Zurück zum Zitat Rahman A, Holman AJ (2010) Fibromyalgia and hypermobility. In: Hakim AJ, Keer R, Grahame R (eds) Hypermobility, fibromyalgia and chronic pain. Churchill Livingstone Elsevier, London Rahman A, Holman AJ (2010) Fibromyalgia and hypermobility. In: Hakim AJ, Keer R, Grahame R (eds) Hypermobility, fibromyalgia and chronic pain. Churchill Livingstone Elsevier, London
7.
Zurück zum Zitat Rombaut L, Malfait F, De Paepe A, Rimbaut S, Verbruggen G, De Wandele I, Calders P (2011) Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 63(7):1979–1987PubMedCrossRef Rombaut L, Malfait F, De Paepe A, Rimbaut S, Verbruggen G, De Wandele I, Calders P (2011) Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 63(7):1979–1987PubMedCrossRef
8.
Zurück zum Zitat Eccleston C, Williams AC, Morley S (2009) Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev (Online) 2, CD007407 Eccleston C, Williams AC, Morley S (2009) Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev (Online) 2, CD007407
10.
Zurück zum Zitat Coughlan GM, Ridout KL, Williams AC, Richardson PH (1995) Attrition from a pain management programme. Br J Clin Psychol Br Psychol Soc 34(Pt 3):471–479CrossRef Coughlan GM, Ridout KL, Williams AC, Richardson PH (1995) Attrition from a pain management programme. Br J Clin Psychol Br Psychol Soc 34(Pt 3):471–479CrossRef
11.
Zurück zum Zitat Nicholas MK (2007) The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 11(2):153–163PubMedCrossRef Nicholas MK (2007) The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 11(2):153–163PubMedCrossRef
12.
Zurück zum Zitat Sullivan MJL, Bishop S, Pivik J (1995) The Pain Catastrophizing Scale: development and validation. Psychol Assess 7:524–532CrossRef Sullivan MJL, Bishop S, Pivik J (1995) The Pain Catastrophizing Scale: development and validation. Psychol Assess 7:524–532CrossRef
13.
Zurück zum Zitat Pincus T, Williams AC, Vogel S, Field A (2004) The development and testing of the depression, anxiety, and positive outlook scale (DAPOS). Pain 109(1–2):181–188PubMedCrossRef Pincus T, Williams AC, Vogel S, Field A (2004) The development and testing of the depression, anxiety, and positive outlook scale (DAPOS). Pain 109(1–2):181–188PubMedCrossRef
14.
Zurück zum Zitat Cleeland CS (1989) Measurement of pain by subjective report. In: Chapman CR, Loeser JD (eds) Advances in Pain Research and Therapy. Raven, New York, pp 391–403 Cleeland CS (1989) Measurement of pain by subjective report. In: Chapman CR, Loeser JD (eds) Advances in Pain Research and Therapy. Raven, New York, pp 391–403
15.
Zurück zum Zitat Miles CL, Pincus T, Carnes D, Homer KE, Taylor SJ, Bremner SA, Rahman A, Underwood M (2011) Can we identify how programmes aimed at promoting self-management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs. Eur J Pain (London England) 15(8):775.e1–775.e11 Miles CL, Pincus T, Carnes D, Homer KE, Taylor SJ, Bremner SA, Rahman A, Underwood M (2011) Can we identify how programmes aimed at promoting self-management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs. Eur J Pain (London England) 15(8):775.e1–775.e11
Metadaten
Titel
Efficacy of an out-patient pain management programme for people with joint hypermobility syndrome
verfasst von
Anisur Rahman
Clare Daniel
Rodney Grahame
Publikationsdatum
01.11.2014
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2014
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2539-9

Weitere Artikel der Ausgabe 11/2014

Clinical Rheumatology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.